These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4862355)

  • 1. Immunofluorescence studies of the bladder defense mechanism. I. Localization of Escherichia coli in the human bladder.
    Drach GW; Cox CE
    J Am Geriatr Soc; 1967 Dec; 15(12):1114-24. PubMed ID: 4862355
    [No Abstract]   [Full Text] [Related]  

  • 2. [Disturbance of the local vesicular defense as a cause of cystitis manifestation].
    Krüger C; Grande R; Wöhrmann W; Commichau R
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):321-6. PubMed ID: 4154604
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of the bladder defense mechanism. II. Postoperative cystitis in the elderly.
    Drach GW; Cox CE
    J Am Geriatr Soc; 1969 Jun; 17(6):529-40. PubMed ID: 4892364
    [No Abstract]   [Full Text] [Related]  

  • 4. An electron microscopic study of the interaction between vesical epitherlium and E. Coli.
    Fukushi Y; Orikasa S; Kagayama M
    Invest Urol; 1979 Jul; 17(1):61-8. PubMed ID: 376485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host defence mechanisms in the bladder. II. Disruption of the layer of mucus.
    Cornish J; Lecamwasam JP; Harrison G; Vanderwee MA; Miller TE
    Br J Exp Pathol; 1988 Dec; 69(6):759-70. PubMed ID: 3064799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody production in urinary bladder infection.
    Uehling DT; Barnhart DD; Seastone CV
    Invest Urol; 1968 Sep; 6(2):211-22. PubMed ID: 4877423
    [No Abstract]   [Full Text] [Related]  

  • 7. Bladder defense mechanisms against urinary tract infections.
    Schaeffer AJ
    Semin Urol; 1983 May; 1(2):106-13. PubMed ID: 6382529
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphocyte sub-populations in the bladder wall in normal bladder, bacterial cystitis and interstitial cystitis.
    Christmas TJ
    Br J Urol; 1994 May; 73(5):508-15. PubMed ID: 8012772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary microflora and the status of local immunity in children with cystitis].
    Sentsova TB; Bobkova VP; Iatsyk PK; Aiazbekov EA; Ulisko IN; Sarkisian AA
    Pediatriia; 1990; (2):19-23. PubMed ID: 2190167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antibacterial effect of normal and infected urinary bladder.
    Hand WL; Smith JW; Sanford JP
    J Lab Clin Med; 1971 Apr; 77(4):605-15. PubMed ID: 4928903
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibodies against hemolysin and cytotoxic necrotizing factor type 1 (CNF1) reduce bladder inflammation in a mouse model of urinary tract infection with toxigenic uropathogenic Escherichia coli.
    Smith MA; Weingarten RA; Russo LM; Ventura CL; O'Brien AD
    Infect Immun; 2015 Apr; 83(4):1661-73. PubMed ID: 25667267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody coating of bacteria in experimental infection of the urinary bladder.
    Riedasch G; Schneider E; Ritz E; Bersch W; Möhring K
    Invest Urol; 1981 Jan; 18(4):247-50. PubMed ID: 7005181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.
    Mulvey MA; Schilling JD; Hultgren SJ
    Infect Immun; 2001 Jul; 69(7):4572-9. PubMed ID: 11402001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody production in urinary tract infections in the rat.
    Heptinstall RH; Ramsden PW
    Invest Urol; 1972 Mar; 9(5):426-30. PubMed ID: 4552605
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibacterial activity of the bladder mucosa.
    Schlager TA; Lohr JA; Hendley JO
    Urol Res; 1993; 21(5):313-7. PubMed ID: 8279086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of intravesical polymorphonuclear leukocytes in experimental cystitis.
    Fukushi Y; Orikasa S
    Invest Urol; 1981 May; 18(8):471-4. PubMed ID: 7014517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of protective immunity after escherichia coli bladder infection in primates. Dependence of the globoside-specific P-fimbrial tip adhesin and its cognate receptor.
    Söderhäll M; Normark S; Ishikawa K; Karlsson K; Teneberg S; Winberg J; Möllby R
    J Clin Invest; 1997 Jul; 100(2):364-72. PubMed ID: 9218513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental bacteriuria: a summary of a research project in progress. II.
    Paquin AJ; Foster EA; Howard RS; Munsie WJ; Gillenwater JY; Mulholland SG
    Trans Am Assoc Genitourin Surg; 1966; 58():73-81. PubMed ID: 5336733
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent advances into the pathogenesis of recurrent urinary tract infections: the bladder as a reservoir for uropathogenic Escherichia coli.
    Schilling JD; Hultgren SJ
    Int J Antimicrob Agents; 2002 Jun; 19(6):457-60. PubMed ID: 12135832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reaction of the vesical wall to bacterial penetration: resistance to attachment, desquamation and leukocytic activity.
    Orikasa S; Hinman F
    Trans Am Assoc Genitourin Surg; 1977; 69():52-60. PubMed ID: 369095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.